Search

Author/Creator Schultz, David

6. Safety and efficacy of oral levosimendan in people with amyotrophic lateral sclerosis (the REFALS study): a randomised, double-blind, placebo-controlled phase 3 trial. Issue 10 (October 2021)

Authors:
Cudkowicz, Merit; Genge, Angela; Maragakis, Nicholas; Petri, Susanne; van den Berg, Leonard; Aho, Valtteri V; Sarapohja, Toni; Kuoppamäki, Mikko; Garratt, Chris; Al-Chalabi, Ammar; Kiernan, Matthew; Mathers, Susan; Henderson, Robert; Needham, Merrilee; Schultz, David; Löscher, Wolfgang; Mitrovic,...
Journal:
Lancet neurology
Issue:
Volume 20:Issue 10(2021)
Page Start:
821
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

9. Evaluation of interprofessional training to strengthen communication and coordination among providers working with expectant mothers and infants affected by substance use. (January 2022)

Authors:
West, Allison; Schultz, David; Schacht, Rebecca L.; Barnet, Beth; DiClemente, Carlo; Leonardi LaCasse, Mary
Journal:
Children and youth services review
Issue:
Volume 132(2022)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗